CY2341B1 - Bicyclic amino acids. - Google Patents
Bicyclic amino acids.Info
- Publication number
- CY2341B1 CY2341B1 CY0300028A CY0300028A CY2341B1 CY 2341 B1 CY2341 B1 CY 2341B1 CY 0300028 A CY0300028 A CY 0300028A CY 0300028 A CY0300028 A CY 0300028A CY 2341 B1 CY2341 B1 CY 2341B1
- Authority
- CY
- Cyprus
- Prior art keywords
- amino acids
- bicyclic amino
- bicyclic
- acids
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19705450A DE19705450A1 (en) | 1997-02-13 | 1997-02-13 | Bicyclic aromatic amino acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY2341B1 true CY2341B1 (en) | 2004-02-06 |
Family
ID=7820093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY0300028A CY2341B1 (en) | 1997-02-13 | 2003-03-17 | Bicyclic amino acids. |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0964856B1 (en) |
| JP (1) | JP4327257B2 (en) |
| KR (1) | KR20000071030A (en) |
| CN (1) | CN1085205C (en) |
| AR (1) | AR010894A1 (en) |
| AT (1) | ATE225776T1 (en) |
| AU (1) | AU735313B2 (en) |
| BR (1) | BR9807345A (en) |
| CA (1) | CA2280727C (en) |
| CY (1) | CY2341B1 (en) |
| CZ (1) | CZ297366B6 (en) |
| DE (2) | DE19705450A1 (en) |
| DK (1) | DK0964856T3 (en) |
| ES (1) | ES2183332T3 (en) |
| HU (1) | HUP0001138A3 (en) |
| ID (1) | ID22533A (en) |
| NO (1) | NO313289B1 (en) |
| PL (1) | PL335101A1 (en) |
| PT (1) | PT964856E (en) |
| RU (1) | RU2187506C2 (en) |
| SI (1) | SI0964856T1 (en) |
| SK (1) | SK284646B6 (en) |
| TR (1) | TR199901962T2 (en) |
| WO (1) | WO1998035949A1 (en) |
| ZA (1) | ZA981178B (en) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040063790A1 (en) * | 1996-05-31 | 2004-04-01 | The Scripps Research Institute | Methods for inhibition of angiogenesis |
| EP1074543B1 (en) | 1998-04-09 | 2012-01-25 | Meiji Seika Pharma Co., Ltd. | Aminopiperidine derivatives as integrin alpha v beta 3 antagonists |
| HUP0203338A2 (en) | 1999-04-13 | 2003-03-28 | Abbott Gmbh & Co. Kg | Integrin receptor ligands |
| AU6316900A (en) | 1999-08-05 | 2001-03-05 | Meiji Seika Kaisha Ltd. | Omega-amino-alpha-hydroxycarboxylic acid derivatives having integrin alphavbeta3antagonism |
| WO2001047874A1 (en) * | 1999-12-24 | 2001-07-05 | Smithkline Beecham P.L.C. | (hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives |
| US6617461B2 (en) * | 2000-01-25 | 2003-09-09 | Kaneka Corporation | Process for preparation of optically active N-substituted azetidine-2-carboxylic acids |
| HUP0302718A3 (en) * | 2000-11-01 | 2011-03-28 | Merck Patent Gmbh | Methods and compositions for the treatment of diseases of the eye |
| RU2294192C2 (en) | 2001-05-30 | 2007-02-27 | Дзе Скриппс Рисерч Инститьют | Nucleic acid delivery system |
| BR0211604A (en) * | 2001-08-01 | 2004-08-24 | Merck Patent Gmbh | Integrin inhibitors for the treatment of eye disease |
| PL371281A1 (en) * | 2002-02-14 | 2005-06-13 | Merck Patent Gmbh | Methods and compositions for the treatment of eye diseases |
| DE10305784A1 (en) * | 2003-02-12 | 2004-08-26 | Merck Patent Gmbh | 3-Oxo-3,4-dihydro-2H-benz-(1,4)-oxazin-6-yl)-propionic acid derivative preparation, for use as integrin inhibitors with e.g. antitumor action, by multi-stage process giving diastereomerically pure product |
| DE10337863A1 (en) | 2003-08-18 | 2005-03-17 | Merck Patent Gmbh | Use of chromene-4-one derivatives |
| US7528106B2 (en) * | 2004-06-04 | 2009-05-05 | The Scripps Research Institute | Compositions and methods for treatment of neovascular diseases |
| UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| RU2518073C2 (en) * | 2008-12-26 | 2014-06-10 | ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД. | Novel bicyclic heterocyclic compound |
| WO2011024987A1 (en) * | 2009-08-31 | 2011-03-03 | 塩野義製薬株式会社 | Aromatic fused heterocyclic derivative and pharmaceutical composition containing same |
| JP6080226B2 (en) | 2012-03-06 | 2017-02-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Benzodioxane for inhibiting leukotriene production in combination with other active substances |
| TW201416354A (en) | 2012-07-17 | 2014-05-01 | Boehringer Ingelheim Int | Inhibitors of leukotriene production |
| WO2015009611A1 (en) | 2013-07-15 | 2015-01-22 | Boehringer Ingelheim International Gmbh | Inhibitors of leukotriene production |
| JP6353899B2 (en) | 2013-07-15 | 2018-07-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Inhibitors of leukotriene production |
| RU2016146826A (en) | 2014-05-30 | 2018-07-04 | Пфайзер Инк. | CARBONITRIL DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS |
| WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
| WO2023076679A1 (en) | 2021-11-01 | 2023-05-04 | Alkahest, Inc. | Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2150550A1 (en) * | 1992-12-01 | 1994-06-09 | Melissa S. Egbertson | Fibrinogen receptor antagonists |
| ES2186720T3 (en) * | 1994-05-27 | 2003-05-16 | Merck & Co Inc | COMPOSITIONS TO INHIBIT OSEA-CALLAST MEDIATED OSAB REABSORPTION. |
| DE19548709A1 (en) * | 1995-12-23 | 1997-07-03 | Merck Patent Gmbh | Tyrosine derivatives |
| KR20000022190A (en) * | 1996-06-28 | 2000-04-25 | 플레믹 크리스티안 | Phenylalamine derivatives as integrin inhibitors |
| DE19654483A1 (en) * | 1996-06-28 | 1998-01-02 | Merck Patent Gmbh | Phenylalanine derivatives |
-
1997
- 1997-02-13 DE DE19705450A patent/DE19705450A1/en not_active Withdrawn
-
1998
- 1998-02-06 AT AT98908063T patent/ATE225776T1/en not_active IP Right Cessation
- 1998-02-06 TR TR1999/01962T patent/TR199901962T2/en unknown
- 1998-02-06 HU HU0001138A patent/HUP0001138A3/en unknown
- 1998-02-06 ID IDW990812A patent/ID22533A/en unknown
- 1998-02-06 RU RU99119223/04A patent/RU2187506C2/en not_active IP Right Cessation
- 1998-02-06 AU AU66206/98A patent/AU735313B2/en not_active Ceased
- 1998-02-06 WO PCT/EP1998/000636 patent/WO1998035949A1/en active IP Right Grant
- 1998-02-06 DE DE59805895T patent/DE59805895D1/en not_active Expired - Lifetime
- 1998-02-06 KR KR1019997007297A patent/KR20000071030A/en not_active Application Discontinuation
- 1998-02-06 CZ CZ0287599A patent/CZ297366B6/en not_active IP Right Cessation
- 1998-02-06 CA CA002280727A patent/CA2280727C/en not_active Expired - Fee Related
- 1998-02-06 CN CN98803959A patent/CN1085205C/en not_active Expired - Fee Related
- 1998-02-06 PL PL98335101A patent/PL335101A1/en unknown
- 1998-02-06 SI SI9830304T patent/SI0964856T1/en unknown
- 1998-02-06 PT PT98908063T patent/PT964856E/en unknown
- 1998-02-06 DK DK98908063T patent/DK0964856T3/en active
- 1998-02-06 BR BR9807345A patent/BR9807345A/en not_active Application Discontinuation
- 1998-02-06 EP EP98908063A patent/EP0964856B1/en not_active Expired - Lifetime
- 1998-02-06 ES ES98908063T patent/ES2183332T3/en not_active Expired - Lifetime
- 1998-02-06 JP JP53530398A patent/JP4327257B2/en not_active Expired - Fee Related
- 1998-02-06 SK SK1071-99A patent/SK284646B6/en unknown
- 1998-02-12 ZA ZA981178A patent/ZA981178B/en unknown
- 1998-02-13 AR ARP980100654A patent/AR010894A1/en not_active Application Discontinuation
-
1999
- 1999-08-12 NO NO19993901A patent/NO313289B1/en not_active IP Right Cessation
-
2003
- 2003-03-17 CY CY0300028A patent/CY2341B1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2341B1 (en) | Bicyclic amino acids. | |
| DE69810130D1 (en) | Rotationspumpe mit tauchrotor | |
| GB9718609D0 (en) | Fusion protein | |
| HU9801045D0 (en) | Substituted diamino-carboxylic acids | |
| DE19881579D2 (en) | Kompressor mit überlastenkopplungseinrichtung | |
| GB9719879D0 (en) | Protein | |
| GB9703681D0 (en) | Protein complemention | |
| EP1018551A4 (en) | Megsin protein | |
| GB9718110D0 (en) | Peptides | |
| AU1999999A (en) | Contryphan peptides | |
| GB9700154D0 (en) | Peptides | |
| ZA984322B (en) | Sucrose-binding proteins | |
| GB9715064D0 (en) | Protein expression | |
| GB9720784D0 (en) | Protein | |
| EP0996457A4 (en) | Fsh-releasing peptides | |
| HK1014964A1 (en) | Somatostatin peptides. | |
| GB9704559D0 (en) | Protease | |
| GB9703103D0 (en) | Protein | |
| GB9719670D0 (en) | Protein | |
| GB9720785D0 (en) | Protein | |
| GB9706556D0 (en) | Peptides | |
| GB9713146D0 (en) | Peptides | |
| GB9701024D0 (en) | Peptides | |
| GB9714075D0 (en) | Novel protein | |
| GB9706119D0 (en) | Novel protein |